Chemoresistance remains a major obstacle to successful treatment of triple negative breast cancer(TNBC).Identification of druggable vulnerabilities is an important aim for TNBC therapy.Here,we report that SERCA2 expre...Chemoresistance remains a major obstacle to successful treatment of triple negative breast cancer(TNBC).Identification of druggable vulnerabilities is an important aim for TNBC therapy.Here,we report that SERCA2 expression correlates with TNBC progression in human patients,which promotes TNBC cell proliferation,migration and chemoresistance.Mechanistically,SERCA2 interacts with LC3B via LIR motif,facilitating WIPI2-independent autophagosome formation to induce autophagy.Autophagy-mediated SERCA2 degradation induces SERCA2 transactivation through a Ca^(2+)/CaMKK/CREB-1 feedback.Moreover,we found that SERCA2-targeting small molecule RL71 enhances SERCA2-LC3B interaction and induces excessive autophagic cell death.The increase in SERCA2 expression predisposes TNBC cells to RL71-induced autophagic cell death in vitro and in vivo.This study elucidates a mechanism by which TNBC cells maintain their high autophagy activity to induce chemoresistance,and suggests increased SERCA2 expression as a druggable vulnerability for TNBC.展开更多
Loss-of-function mutations frequently occur in tumor suppressor genes,i.e.,p53,during the malignant progression of various cancers.Whether any intrinsic suppressor carries a rare mutation is largely unknown.Here,we de...Loss-of-function mutations frequently occur in tumor suppressor genes,i.e.,p53,during the malignant progression of various cancers.Whether any intrinsic suppressor carries a rare mutation is largely unknown.Here,we demonstrate that intracellular cytokine-like protein 1(CYTL1)plays a key role in preventing the robust glycolytic switching characteristic of breast cancer.A low intracellular CYTL1 level,not its mutation,is required for metabolic reprogramming.展开更多
基金This study was funded by National Natural Science Foundation of China(Nos.21937005 and 81974504)Natural Science Foundation of Jiangsu Province(No.BK 20191251,China)+1 种基金the Fundamental Research Funds for the Central Universities(China)National Key R&D·Program of China(No.2017YFA0506000).
文摘Chemoresistance remains a major obstacle to successful treatment of triple negative breast cancer(TNBC).Identification of druggable vulnerabilities is an important aim for TNBC therapy.Here,we report that SERCA2 expression correlates with TNBC progression in human patients,which promotes TNBC cell proliferation,migration and chemoresistance.Mechanistically,SERCA2 interacts with LC3B via LIR motif,facilitating WIPI2-independent autophagosome formation to induce autophagy.Autophagy-mediated SERCA2 degradation induces SERCA2 transactivation through a Ca^(2+)/CaMKK/CREB-1 feedback.Moreover,we found that SERCA2-targeting small molecule RL71 enhances SERCA2-LC3B interaction and induces excessive autophagic cell death.The increase in SERCA2 expression predisposes TNBC cells to RL71-induced autophagic cell death in vitro and in vivo.This study elucidates a mechanism by which TNBC cells maintain their high autophagy activity to induce chemoresistance,and suggests increased SERCA2 expression as a druggable vulnerability for TNBC.
基金This study was supported by the National Natural Science Foundation of China(Nos.81730100,21937005,81974504)the Natural Science Foundation of Jiangsu Province(No.BK20191251)the Fundamental Research Funds for the Central Universities.
文摘Loss-of-function mutations frequently occur in tumor suppressor genes,i.e.,p53,during the malignant progression of various cancers.Whether any intrinsic suppressor carries a rare mutation is largely unknown.Here,we demonstrate that intracellular cytokine-like protein 1(CYTL1)plays a key role in preventing the robust glycolytic switching characteristic of breast cancer.A low intracellular CYTL1 level,not its mutation,is required for metabolic reprogramming.
